- Poster Presentation
- Open Access
- Published:
Functional analysis of normal and DCIS modified breast myoepithelial cells
Breast Cancer Research volume 8, Article number: P14 (2006)
Background
Normal breast myoepithelial cells have been shown to exhibit tumour-suppressor activity mediated, in part, by downregulation of MMP expression [1]. DCIS myoepithelial cells have an altered phenotype as demonstrated by a different gene expression profile [2]. We have identified upregulation of α(v)β6 integrin on myoepithelial cells in a subset of DCIS; however, the role of α(v)β6 in this context is not clear. α(v)β6 is not expressed by normal epithelial cells, but is expressed in some cancers where it promotes tumour cell invasion and enhances MMP expression.
Methods
The purpose of this project is to investigate the hypothesis that DCIS-associated myoepithelial cells lose their tumour suppressor effect and acquire a tumour promoting activity. There are three general aims: (1) to generate a series of myoepithelial cell models to mimic DCIS-associated myoepithelial cells and overexpress α(v)β6 to assess the contribution of this integrin; (2) to compare tumour suppressor/promoter properties of normal, α(v)β6 overexpressing and DCIS-associated myoepithelial cells; and (3) to examine the effect of de novo α(v)β6 expression on the biological activity of myoepithelial cells.
Results
We have fully characterised an immortalised myoepithelial cell line, engineered it to overexpress α(v)β6 and determined that it is functional. We are starting to examine the morphology and phenotype of these cells to determine any differences, and we have been able to show the parental cell line is able to recapitulate the tumour suppressor effect in in vitro systems. We are now looking into what effect the expression of α(v)β6 has in these systems. We are also in the process of trying to create further myoepithelial cell lines from primary cells isolated from patient tissue.
Conclusion
Through this work we hope to identify the role α(v)β6 expression has in DCIS myoepithelial cells with the goal of making this integrin a viable therapeutic target in the future.
References
- 1.
Jones J, Shaw J, Pringle J, Wlaker R: Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol. 2003, 201: 562-572. 10.1002/path.1483.
- 2.
Allinen M, Beroukhim R, Cai L, et al: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6: 17-32. 10.1016/j.ccr.2004.06.010.
Acknowledgements
This work was funded by Breast Cancer Campaign.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Allen, M., Mulligan, K., Clark, S. et al. Functional analysis of normal and DCIS modified breast myoepithelial cells. Breast Cancer Res 8, P14 (2006). https://doi.org/10.1186/bcr1569
Published:
Keywords
- Integrin
- Myoepithelial Cell
- Tumour Cell Invasion
- Parental Cell Line
- Normal Epithelial Cell
